Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Provan

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Hematology (Amsterdam, Netherlands)|July 6, 2013
Immune thrombocytopeniaDrew Provan
American Journal of Hematology|December 8, 2023
Real-world evidence confirms thrombopoietin receptor agonists are safe and effective for all stages of immune thrombocytopeniaDrew Provan
European Journal of Haematology. Supplementum|February 10, 2009
Characteristics of immune thrombocytopenic purpura: a guide for clinical practiceDrew Provan
Mayo Clinic Proceedings|April 7, 2004
Management of immune thrombocytopenic purpura in adultsRoberto Stasi, Drew Provan
Hematology. American Society of Hematology. Education Program|December 17, 2008
Helicobacter pylori and Chronic ITPRoberto Stasi, Drew Provan
British Journal of Haematology|August 30, 2002
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsDrew Provan, Adrian Newland
Journal of Pediatric Hematology/Oncology|December 12, 2003
Idiopathic thrombocytopenic purpura in adultsDrew Provan, Adrian Newland
Ebiomedicine|January 25, 2022
Recent advances in the mechanisms and treatment of immune thrombocytopeniaDrew Provan, John W Semple
The New England Journal of Medicine|February 11, 2011
Guidelines for immune thrombocytopeniaDrew Provan, Adrian C Newland
Current Opinion in Hematology|July 5, 2012
The immunopathogenesis of immune thrombocytopenia: T cells still take center-stageJohn W Semple, Drew Provan
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Hematology (Amsterdam, Netherlands)|July 6, 2013
Immune thrombocytopeniaDrew Provan
American Journal of Hematology|December 8, 2023
Real-world evidence confirms thrombopoietin receptor agonists are safe and effective for all stages of immune thrombocytopeniaDrew Provan
European Journal of Haematology. Supplementum|February 10, 2009
Characteristics of immune thrombocytopenic purpura: a guide for clinical practiceDrew Provan
Mayo Clinic Proceedings|April 7, 2004
Management of immune thrombocytopenic purpura in adultsRoberto Stasi, Drew Provan
Hematology. American Society of Hematology. Education Program|December 17, 2008
Helicobacter pylori and Chronic ITPRoberto Stasi, Drew Provan
British Journal of Haematology|August 30, 2002
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adultsDrew Provan, Adrian Newland
Journal of Pediatric Hematology/Oncology|December 12, 2003
Idiopathic thrombocytopenic purpura in adultsDrew Provan, Adrian Newland
Ebiomedicine|January 25, 2022
Recent advances in the mechanisms and treatment of immune thrombocytopeniaDrew Provan, John W Semple
The New England Journal of Medicine|February 11, 2011
Guidelines for immune thrombocytopeniaDrew Provan, Adrian C Newland
Current Opinion in Hematology|July 5, 2012
The immunopathogenesis of immune thrombocytopenia: T cells still take center-stageJohn W Semple, Drew Provan
Pageof 9